| HILAX | VIHAX | HILAX / VIHAX | |
| Total Expense Ratio | 1.18 | 0.16 | 737% |
| Annual Report Gross Expense Ratio | 1.18 | 0.16 | 737% |
| Fund Existence | 16 years | 10 years | - |
| Gain YTD | 18.641 | 17.601 | 106% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2000 | 3000 | 67% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 16.5B | 21.9B | 75% |
| Annual Yield % from dividends | 2.49 | 3.45 | 72% |
| Returns for 1 year | 24.51 | 25.96 | 94% |
| Returns for 3 years | 85.69 | 75.63 | 113% |
| Returns for 5 years | 106.92 | 66.41 | 161% |
| Returns for 10 years | 144.10 | 108.07 | 133% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RMOCX | 19.25 | 0.23 | +1.21% |
| Victory RS Mid Cap Growth C | |||
| CIVHX | 22.29 | 0.17 | +0.77% |
| American Funds Intl Vntg 529-F-3 | |||
| GSYPX | 45.93 | 0.22 | +0.48% |
| Goldman Sachs Small Cap Value P | |||
| PASTX | 68.29 | 0.18 | +0.26% |
| T. Rowe Price Science & Tech Adv | |||
| JMNCX | 12.25 | -0.01 | -0.08% |
| JPMorgan Research Market Neutral C | |||